Laidlaw Venture Partners Continues Strategic Growth with Addition of Jeff Conroy and George Serafin to its Board of Advisorsdan2020-06-25T18:48:28-04:00June 25th, 2020|Read More
Laidlaw served as Co-Manager on the $50,000,000 Follow-On Offering for Soleno Therapeutics (SLNO) with Guggenheim Partnersdan2020-06-25T18:43:05-04:00June 25th, 2020|Read More
Laidlaw Venture Partners Adds Industry Leading CEOs Jeffrey O’Donnell and Dr. Ann Marie Sastry to its Board of Advisorsdan2020-06-15T19:19:50-04:00June 15th, 2020|Read More
Laidlaw served as Sole Book-Runner on the $5mm Follow-On Offering for Hoth Therapeutics (HOTH)dan2020-05-24T15:09:23-04:00May 24th, 2020|Read More
Laidlaw served as Introducing Broker on the $10.8mm financing for Biosig Technologies (BSGM), through its subsidiary ViralClear.dan2020-05-20T15:26:48-04:00May 20th, 2020|Read More
Stay In Touch